<DOC>
	<DOCNO>NCT02181556</DOCNO>
	<brief_summary>One treatment generally use treat disease chemotherapy call FOLFIRI . The purpose study improve efficacy chemotherapy add protein , similar immunoglobulin , aflibercept , assess tolerance . Aflibercept protein already study treatment metastatic colorectal cancer , combination chemotherapy involve irinotecan addition 5FU ( FOLFIRI ) 2nd line treatment . It market Europe authorize United States . Its addition chemotherapy combination fact bring benefit term progression-free survival overall survival . The purpose study evaluate efficacy tolerance combination rather initial approach treatment metastatic colorectal cancer hence evaluate 1st line treatment</brief_summary>
	<brief_title>Efficacy Safety Aflibercept Combination With FOLFIRI Chemotherapy 1st Line Treatment Patients With Metastatic Colorectal Cancer</brief_title>
	<detailed_description />
	<mesh_term>Colorectal Neoplasms</mesh_term>
	<criteria>Age ≥ 18 year Overall state per WHO ≤ 2 Life expectancy &gt; 3 month Metastatic adenocarcinoma rectum colon histologically proven primary tumor metastasis Unresectable metastasis ( metastasis ) and/or inoperable patient Patient eligible 1st line treatment associate 5 FUIrinotecan ( FOLFIRI ) aflibercept At least one measurable target lesion accord RECIST criterion v1.1 previously irradiate Absence prior treatment metastatic disease . Prior adjuvant chemotherapy complete least 12 month metastatic cancer diagnosis authorize Satisfactory laboratory panel : Hb &gt; 9 g/dl , polynuclear neutrophil &gt; 1500 /mm3 , platelet &gt; 100,000/mm3 , total bilirubin &lt; 1.5 x LSN , creatinine clearance &gt; 50mL/min ( cockcroftGault formula appendix 4 ) , ALP &lt; 5 x UNL , AST ALT &lt; 5 x UNL , GGT &lt; 5 x UNL , Proteinuria urine dipstick &lt; 2+ . If &gt; 2+ test 24hour proteinuria , &lt; 1 g Patients whose primary tumor place present clinical symptom ( occlusion ; hemorrhage ) Brain metastases Gilbert 's syndrome Uncontrolled hypercalcemia Hypertension keep control ( SBP &gt; 150 mmHg DBP &gt; 100 mmHg ) history hypertensive crisis hypertensive encephalopathy Any unbalance active disease last 6 month : liver failure , kidney failure , respiratory failure , congestive heart failure , unstable angina , myocardial infarction , significant arrhythmia ( Patients treat anticoagulant ( coumadin , warfarin ) eligible strict monitoring INR possible ) Significant surgical intervention within 28 day start treatment Presence active gastroduodenal ulcer , nonhealed wound bone fracture Antitumor treatment include study ( chemotherapy , target therapy , immunotherapy ) History malignant hemopathy cancer except treat 5 year ago consider heal , situ carcinoma uterine cervix treat skin cancer ( except melanoma ) Pregnant breastfeed woman , woman childbearing age take pregnancy test , absence effective contraception patient ( men and/or woman ) childbearing age Any contraindication drug use study Impossible meet medical followup requirement study geographic , social psychological reason</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2016</verification_date>
	<keyword>colorectal cancer</keyword>
	<keyword>Metastatic</keyword>
</DOC>